1705-16-4 Usage
Description
3-Trifluoromethylbutyrophenone is a chemical compound with the chemical formula C13H11F3O. It is a potent dopamine antagonist that has been utilized in scientific research to study the effects of dopamine activity in the brain. 3-trifluoromethylbutyrophenone is also considered a potential candidate for the development of new medications targeting neurological and psychiatric disorders due to its ability to modulate dopamine receptors.
Uses
Used in Scientific Research:
3-Trifluoromethylbutyrophenone is used as a research tool for studying the role of dopamine in the brain, which is crucial for understanding various neurological and psychiatric conditions.
Used in Pharmaceutical Development:
It is utilized as a potential candidate for developing new medications for neurological and psychiatric disorders, given its ability to modulate dopamine receptors.
Used in Antipsychotic and Sedative Treatment:
3-Trifluoromethylbutyrophenone is used as a compound under investigation for its potential antipsychotic and sedative effects, which may contribute to the treatment of conditions such as schizophrenia and bipolar disorder.
Check Digit Verification of cas no
The CAS Registry Mumber 1705-16-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,0 and 5 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1705-16:
(6*1)+(5*7)+(4*0)+(3*5)+(2*1)+(1*6)=64
64 % 10 = 4
So 1705-16-4 is a valid CAS Registry Number.
1705-16-4Relevant articles and documents
CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE
-
Paragraph 000505; 000506; 000527; 000528, (2018/01/17)
Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.
Synthesis and evaluation of the anticonvulsant activity of a series of 2-amino-1-phenyl-1-propranols derived from the metabolites of the antidepressant bupropion
Musso, David L.,Mehta, Nariman B.,Soroko, Francis E.
, p. 1 - 6 (2007/10/03)
A series of 2-amino-1-phenyl-1-propanols that are structurally related to known metabolites of bupropion, 1 (Wellbutrin) were synthesized and evaluated as potential anticonvulsants. The (R*,R*)-2-tert-butylamino-1-(3-trifluoromethylphenyl) propanol 20 had an ED50 of 16.5 ± 2.8 mg/kg ip in mice in the maximal electroshock screen and was chosen for further evaluation.
